Neuro is hot and CranioSense is right in the thick of it, focused on providing more efficient and accurate diagnosis and monitoring for those at risk of elevated brain pressure. Today, Joshua Colls presented on behalf of CranioSense at the Neurotrauma Assessment, Diagnosis, and Monitoring State of Technology event in DC hosted by our friends at Biomedical Advanced Research and Development Authority (BARDA) and if you missed it, you missed out! Thank you to Josh for sharing recent CranioSense traction with the neurotrauma community and to the community as a whole for supporting innovation. Also, a huge shout out to Moberg Analytics for highlighting the need for future proofed clinical guidelines that support bringing the best solutions to patients as efficiently as possible.
CranioSense’s Post
More Relevant Posts
-
Available for #License: Emory University researchers have developed a cutting-edge multimodal approach using both CT and MRI scans to predict atrial fibrillation (AF) recurrence after catheter ablation. By identifying shape differences in the left atrium, this technology helps pinpoint regions for targeted treatment, improving patient outcomes. Developed by a team of researchers led by Abhishek Midya and Anant Madabhushi. Learn more about this innovative approach to AF management! https://lnkd.in/eB5R4uDU
-
-
T2 mapping is a crucial technique in quantitative #MR imaging, offering detailed insights into various tissue characteristics by measuring transverse relaxation times (T2). Using the multi-echo spin echo sequence, T2 mapping can provide objective metrics, allowing the detection and the follow-up of conditions like inflammation and fibrosis. In our latest #GoodtoKnow edition, Iva Vilas-Boas Ribeiro, PhD explains how T2 mapping works in research and clinical practice. Visit our website to learn more and download the full PDF https://bit.ly/4diN7tK #CanonMedical #MadePossible
-
-
TV & Podcast Host @Wealth Without Bay Street Podcast | Authorized Infinite Banking Practitioner
Today's medical imaging might just be the tip of the iceberg. Codi Gharagouzloo, CEO of Imaginostics, is pioneering advancements with MRI Scanning #technology that might revolutionize how we detect and manage diseases. Harnessing physics for medical diagnostics emphasizes that "if you can't see something, you're not going to be able to beat it." Codi's passion for making significant health impacts through advanced diagnostics is at the heart of Imaginostics' mission. Don't miss out on this fascinating shift in health care—stay tuned for more updates! 10X Clarity: Pioneering Disease Detection through Imaginostics https://brnw.ch/21wKfgw #WWBS #RichardCanfield #BeYourOwnBanker #EarlyDiseaseDetection #Imaginostics #MRIRisks #InnovationInHealth #RevolutionizingMRI #MRIBreakthrough #HealthTech #PioneeringMRITech #SpeedingCures #CuttingInsuranceCosts #SolvingAlzheimers
-
💡 Good to Know ! 🧠 Do you know how #T2mapping is working and how it can provide metrics to evaluate tissue properties? In our latest #GoodtoKnow #MRI, my colleague Iva Vilas-Boas Ribeiro explains how T2 mapping exploration is performed in research and clinical practice. Visit our website to learn more and download the full PDF https://bit.ly/4diN7tK
T2 mapping is a crucial technique in quantitative #MR imaging, offering detailed insights into various tissue characteristics by measuring transverse relaxation times (T2). Using the multi-echo spin echo sequence, T2 mapping can provide objective metrics, allowing the detection and the follow-up of conditions like inflammation and fibrosis. In our latest #GoodtoKnow edition, Iva Vilas-Boas Ribeiro, PhD explains how T2 mapping works in research and clinical practice. Visit our website to learn more and download the full PDF https://bit.ly/4diN7tK #CanonMedical #MadePossible
-
-
✨ Exciting Scientific Breakthrough!✨ Researchers have discovered a method to make mice’s skin temporarily transparent using a common food dye! This innovation could open new possibilities in medical imaging, from easier blood draws to early disease detection. 💡🔬 Could this be the future of non-invasive diagnostics? Stay tuned! 🚀 #MedicalInnovation #ScienceAndTech #HealthcareRevolution #BioByPriti #ResearchBreakthrough #LinkedInScience
-
Founder&CEO at Subtle Medical. FDA-cleared AI for faster, better, smarter radiology exams. Forbes 30-under-30.
More in-dpeth review of our latest FDA-pending technology #SubtleSYNTH. Multi-center Multi-reader study shows it leverages more data to improves the spine MR exam further with additional quality and efficiency gains. #SubtleMR #GenAI
🎉 Great news! Subtle Medical is excited to have our Lead Research Scientist, T. Campbell Arnold, speaking at two sessions during #ASSR24 again this year! Campbell will present the latest in our #SubtleSYNTH research developments, including 3D STIR synthesis and a quantitative and qualitative validation for synthetic #STIR: 🚀 Talk 1: Deep-Learning-Based STIR Synthesis for Spine #MRI with Variable T1 and T2 Slice Thickness 📅 Date: Friday, February 16th ⏰ Time: 3:40 - 5:00 PM PST Talk 2: Feasibility of a Deep Learning-Generated MRI Sequence for Diagnosis 📅 Date: Saturday, February 17th ⏰ Time: 3:45 - 5:00 PM PST If you can't make it, DM or reach out to us at the link below to schedule a time to meet during the conference! #SubtleMedical #ASSR2024 #ASSR24 Wende Gibbs 👉 https://lnkd.in/gh4S5dwQ
-
Recruitment & Talent Search in MedDevices | specialised in Neuromodulation & Neuro Imaging 🧠⚡🩻
Exciting News! Ultromics, an AI-driven health tech company from Oxford, has teamed up with Pfizer to validate its EchoGo® Amyloidosis algorithm for detecting cardiac amyloidosis. This breakthrough technology, leveraging deep learning on routine ultrasound scans, aims to identify the disease early, crucial for optimal treatment. Cardiac #amyloidosis results from the accumulation of abnormal proteins within the heart, impairing its ability to pump blood. Over time, the build-up of these proteins causes the heart muscle to stiffen, eventually leading to heart failure. With EchoGo, #AI can notify clinicians of disease presence and offer an early warning, which is critical to help slow disease progression. Ultromics, known for FDA-cleared Heart Failure detection algorithms, aims to secure clearance for EchoGo Amyloidosis, already designated a Breakthrough Device. Their history includes FDA-cleared EchoGo Pro for coronary artery disease, and participation in the FDA's Total Product Life Cycle Advisory Program (TAP) Pilot. Stay tuned for advancements in AI-enhanced cardiac care! #HealthTech #AIinMedicine #CardiacCare #Innovation #ai #cardiology #medicalsoftware #EchoGo https://lnkd.in/gSSWGFKs
-
#mdpiopenaccess #mdpichildren Call for readings for our Highly Cited Paper in 2022👏 Title: Effects of Vision Therapy on Bilateral Amblyopia Unresponsive to Conventional Treatment: A Retrospective Comparative Study by Dr. Yu-Te Huang et al. View full-text on:
-
Have a look at the publication highlighting our #ACCERO #Rex Stent. This study presents the first five clinical applications of our device in treating fusiform giant cerebral aneurysms, showing significant advancements in patient outcomes. Key highlights: - Successful and safe implantation of ACCERO Rex Stents in all five patients - Significant aneurysm size reduction observed - Promising short-term outcomes with no major technical complications The study shows that the device offers another treatment option for rare cerebral fusiform giant aneurysms with very large parent vessels. Read the full paper here: https://lnkd.in/eD-ZM4b7
A Giant Stent for Giant Cerebral Aneurysms—The Accero®-Rex-Stent
mdpi.com
-
#GTX #dialogues Cardiac imaging plays a crucial role in the evaluation & management of patients w/ CHD & advancements in #cvImaging techniques will likely find rapid clinical application in the assessment of patients w/ CHD Read the full scientific statement in #JACC: bit.ly/48OrOyl #AiSteth #SeeTheSound #NCDs #SDG3 #ActonNCDs
-
Clinical Research Manager at Vivonics, Inc
7moCranioSense Thanks for the opportunity!